214853927 | PUO | 56987195 | | 1123738 | 3/30/2006 12:00:00 AM | congestive heart failure | | DIS | Admission Date: 3/30/2006 Report Status: 

Discharge Date: 10/13/2006 ****** FINAL DISCHARGE ORDERS ****** BANDEMER , MILLICENT 778-55-94-7 Jers Tole Service: CAR DISCHARGE PATIENT ON: 7/12/06 AT 02:00 PM CONTINGENT UPON Not Applicable WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: HAUB , PERRY , M.D. CODE STATUS: No CPR , No defib , No intubation , No pressors DISPOSITION: Home w/ services DISCHARGE MEDICATIONS: ASA 325 MG PO DAILY LIPITOR ( ATORVASTATIN ) 80 MG PO DAILY Override Notice: Override added on 4/30/06 by ODER , STEWART K. , M.D. , PH.D. on order for MULTIVITAMIN THERAPEUTIC PO ( ref # 282334571 ) POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp; NIACIN , VIT. B-3 Reason for override: aware PLAVIX ( CLOPIDOGREL ) 75 MG PO DAILY Starting Today March LOVENOX ( ENOXAPARIN ) 80 MG SC BID Starting Today March Instructions: continue until your INR is &gt; 2.0 ( will be instructed to stop by the coumadin clinic ) NEXIUM ( ESOMEPRAZOLE ) 20 MG PO DAILY FOLIC ACID 1 MG PO DAILY HYDRALAZINE HCL 50 MG PO TID Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
ATROVENT NEBULIZER ( IPRATROPIUM NEBULIZER ) 0.5 MG INH QID PRN Wheezing ISOSORBIDE MONONITRATE ( SR ) 90 MG PO DAILY Food/Drug Interaction Instruction Give on an empty stomach ( give 1hr before or 2hr after food ) LEVOFLOXACIN 500 MG PO DAILY X 14 Days Starting Today March Food/Drug Interaction Instruction Administer iron products a minimum of 2 hours before or after a levofloxacin or ciprofloxacin dose dose If on tube feeds , please cycle ( hold 1 hr before to 2 hr after ) Take 2 hours before or 2 hours after dairy products. 
LISINOPRIL 20 MG PO DAILY Override Notice: Override added on 10/15/06 by ODER , STEWART K. , M.D. , PH.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 556055370 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: aware Previous override information: Override added on 10/15/06 by ODER , STEWART K. , M.D. , PH.D. on order for KCL SLOW RELEASE PO ( ref # 098265321 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: awaer Previous override information: Override added on 3/12/06 by : POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; LISINOPRIL Reason for override: will monitor Previous Override Notice Override added on 10/19/06 by MARTER , BRYON M. , M.D. , PH.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 821750797 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: md aware Previous override information: Override added on 10/19/06 by MARTER , BRYON M. , M.D. , PH.D. on order for POTASSIUM CHLORIDE IV ( ref # 143881763 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: md aware Previous override information: Override added on 6/2/06 by ODER , STEWART K. , M.D. , PH.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 446944960 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: mda Previous override information: Override added on 6/2/06 by ODER , STEWART K. , M.D. , PH.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 842738538 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: aware Previous override information: Override added on 4/30/06 by ODER , STEWART K. , M.D. , PH.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 944706119 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: aware TOPROL XL ( METOPROLOL SUCCINATE EXTENDED RELEASE ) 50 MG PO DAILY Starting IN PM March Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
Number of Doses Required ( approximate ): 5 MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... ) 1 TAB PO DAILY Alert overridden: Override added on 4/30/06 by ODER , STEWART K. , M.D. , PH.D. POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp; NIACIN , VIT. B-3 Reason for override: aware THIAMINE HCL 100 MG PO DAILY TORSEMIDE 40 MG PO DAILY Starting IN AM March TRAZODONE 50 MG PO BEDTIME PRN Insomnia COUMADIN ( WARFARIN SODIUM ) 3 MG PO QPM Starting ROUTINE , 20:00 ( Standard Admin Time ) Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden: Override added on 7/12/06 by : POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: ATORVASTATIN CALCIUM &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN &amp; WARFARIN Reason for override: md aware DIET: Fluid restriction DIET: House / Low chol/low sat. 
fat DIET: House / ADA 1800 cals/dy DIET: 2 gram Sodium ACTIVITY: Walking as tolerated FOLLOW UP APPOINTMENT( S ): Dr. Stautz , cardiology 10/21/06 2:20 PM scheduled , Dr. Enamorado , Wil Medical Center call him for an appointment this week , Arrange INR to be drawn on 1/25/06 with f/u INR's to be drawn every 4 days. 
INR's will be followed by PUO Coumadin Clinic to be drawn by VNA initially ALLERGY: NKA ADMIT DIAGNOSIS: congestive heart failure PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) congestive heart failure OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay bph hypertension copd ( fev1 1.4L ) right bundle branch block alcohol abuse ( alcohol abuse ) ischemic cardiomyopathy ( 5 ) cardiomyopathy ( cardiomyopathy ) coronary artery disease ( coronary artery disease ) diabetes mellitus ( diabetes mellitus type 2 ) chf ( congestive heart failure ) OPERATIONS AND PROCEDURES: OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) diuresis BRIEF RESUME OF HOSPITAL COURSE: cc: SOB *** HPI: 73 yo man with NSCLCa , ischemic CMP with progressive SOB for 48-72 hours. 
Well over weekend. 
Admits to missing torsemide yesterday. 
Baseline ADLS and climb one flight stairs. 
Two pillow orthopnea. 
No CP. 
Unable to sleep o/n secondary SOB. 
? 1 month R LEE. *** PMH: ICMP ( EF 25-30% ) , diastolic dysfunction , cyper to RCA 9/21 , cypher to LAD 4/3 , NSLCa ( Stage IIIA small cell CA ) , BPH , HTN , COPD fev1 1.4 L , DM II *** Meds - lisinopril 40 , lipitor 80 , plavix 75 , ASA 325 , folic acid 1 , hydral 50 TID , Toprol XL 50 , MVI , thiamine 100 , torsemide 40 , imdur 90 , trazadone 25 , ambien 5 , nexium , mvi , glyburide 5 *** allgy - NKDA *** Status PERRL , EOMI , anicteric , OP clear Supple , no thyromegaly , no LAD 2+ carotids , JVP 10-12 cm R: crackles base Left: very decreased BS throughout RRR nl S1 , S2 , + S3 abd benign trace LEE *** EKG NSR - 92 , RBBB , TWI V5-V6 Echo 10/24 - LV 20-30% , regional WMA , diastolic dysfunction Cath 4/3 - R dom , no sig LM , LAD prox 55% , IVUS with severe plaque w/ lumen diameter 2 X 1.4 , successful stenting LAD to 0% no sig LCX dz , RCA CXR - pulm edema , CT PE - Large L upper lobe mass , subsegmental PE Trop 0.17 -&gt; 0.30 -&gt; 0.43 ( med management only , stop trending ) *** Impression: 73 yo man with ICM with heart exacerbation + PE ( ? 
leading in part to heart failure exacerbation ) 1 ) CV - P - ICMP with volume overload - diuresis ( twice home dose torsemide ) with successful diuresis to weight of 69.5 to 67.1 kg ( at lower weight became hypotensive ) - cont send on previous home diuretic regimen and same HTN meds with decrease of lisinopril to 20 mg daily - re: PE -&gt; no RV strain on echo , on exam and EKG , started on treatment dose lovenox , to transition to coumadin at home with goal INR 2-3 ( indefinitely ) - I - CAD with trop leak - combo CHF exacerbation + PE? - cont ASA , plavix , ( on Rx dose lovenox for PE ) , BB , nitrate. 
Recheck in am - mild bump again .17 to 0.30 to 0.43 - given overall picture with advanced lung CA , would not recath -&gt; continued optimal medical management - R - tele -&gt; no issues 2 ) Onc - currently undergoing XRT ( continued in house ) , primary oncologist Dr. Enamorado , aware , to see again as outpatient 3 ) HEME - subsegmental PE - lovenox BID , with bridge to coumadin DNR- DNI ADDITIONAL COMMENTS: Take all medications as prescribed. 
You have several changes to your medications. 
You are now only taking 20 mg of Lisinopril. 
Also , you are now taking Coumadin 3mg daily ( the cardiology coumadin clinic will tell you how to adjust your dose ) and lovenox 80 mg twice daily ( you will stop these injections when you are told to by the coumadin clinic ). 
If you develop chest pain , shortness of breath , or other worrisome symptoms , please seek medical attention. 
DISCHARGE CONDITION: Stable TO DO/PLAN: - Cont lovenox - Have INR checked on Thursday by VNA nurse , results to Totin Hospital And Clinic Cardiology Coumadin clinic , to adjust coumadin dose. 
No dictated summary ENTERED BY: MARTER , BRYON M. , M.D. , PH.D. ( VD96 ) 7/12/06 @ 01:05 PM ****** END OF DISCHARGE ORDERS ******